



2021 Legislative Update  
Board of Dentistry 
 
The following bill was enacted by the General Assembly during the 2021 legislative session and 
may impact the Board of Dentistry and/or the Board of Dentistry licensees:  
 
 
Prescribers to Offer Prescription for Naloxone Hydrochloride & Provide Overdose Education, 
S.571/Act 22 
The Act adds Section 44-53-361 to require a prescriber to offer a prescription for naloxone 
hydrochloride or another drug approved by the FDA for the complete or partial reversal of opioid 
depression to a patient if (a) the prescription is 50 or more MME of an opioid medication per day; 
(b) the opioid is prescribed concurrently with a prescription for benzodiazepine, or (c) patient 
presents with certain increased risk for overdose. The Act also requires a prescriber to offer the 
same patient, or the parent/guardian of a minor patient, overdose education. A prescriber who 
fails to comply with these requirements may be subject to discipline by the appropriate licensing 
board. 
 
Effective Date: July 25, 2021 
 
 
Disclaimer: This legislative update is not intended as legal advice. LLR is providing this 
legislative update to notify licensees of recently enacted legislation that may impact his or her 
practice area or license.  This legislative update provides only a high level overview of enacted 
legislation and licensees are urged to review the entire enacted legislation, which is available 
in the hyperlinks above.  
 
